Balloon implant for prostate cancer passes Long-Term safety check

NCT ID NCT05354440

Ongoing Disease control Sponsor: BioProtect Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study follows 80 prostate cancer patients who previously received a BioProtect balloon implant during radiation therapy. Researchers are checking for long-term side effects in the bladder and bowel, and how patients' quality of life holds up over time. The goal is to make sure the implant remains safe years after treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: BioProtect balloon implant system
What this could lead to: If successful, this study could confirm that the BioProtect balloon implant is a safe long-term option to reduce side effects during prostate cancer radiation therapy.
What could go wrong: This is a small, observational follow-up study with only 80 participants, so results may not apply to all patients. It does not test a new treatment, only monitors past outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER

Contacts and locations

Locations

Assuta Ashdod medical center

Ashdod, Israel
Cuf Porto institution

Porto, Portugal
Institute of Maria Skłodowska - Curie

Warsaw, Poland
Maastricht radiation oncology

Maastricht, Netherlands
Rabin Medical Center

Petah Tikva, Israel
St Luke's Radiation Oncology

Dublin, Ireland

More trials for these conditions

Other studies related to the condition(s) this trial covers.